The Differential Effects of Angiotensin II Type 1 Receptor Blockers on Microalbuminuria in Relation to Low-Grade Inflammation in Metabolic Hypertensive Patients

Yuichiro Yano, Satoshi Hoshide, Joji Ishikawa, Chishio Noguchi, Daisuke Tukui, Hidaka Takanori, Masashi Tada, Yoshimasa Kanemaru, Ayako Yano, Shizukiyo Ishikawa, Kazuyuki Shimada, Kazuomi Kario

Research output: Contribution to journalArticlepeer-review

46 Scopus citations

Abstract

Background: A dual angiotensin type 1 receptor blocker (ARB)/peroxisome proliferator-activated receptor-γ (PPARγ) agonist telmisartan may be more useful for microalbuminuria reduction than ARBs with no PPARγ agonistic action. We investigated whether there is a difference between the effects of telmisartan and valsartan with respect to microalbuminuria reduction, and the association with improvement of metabolic features or suppression of the inflammatory state. Methods: Fifty-three patients who had metabolic syndrome and had been taking valsartan were recruited. All of these patients were randomly assigned to replace valsartan by telmisartan (telmisartan group; n = 30) or to keep taking valsartan (control group; n = 21). Various parameters were measured at baseline and 12 weeks after randomization. Results: There were no significant changes in blood pressure (BP), glucose, and lipid parameters between baseline and 12 weeks after randomization in either group. There was a significant increase in high molecular weight adiponectin in the telmisartan group (4.6 v 5.0 μg/mL, P = .024), whereas there was no significant change in the control group. The reductions of microalbuminuria and high-sensitivity C-reactive protein (hs-CRP) were significant in the telmisartan group (28.1 v 18.9 mg/g · Cr and 0.77 v 0.60 mg/L, respectively, P = .001 and P = .022), whereas there was no significant change in the control group. The reductions of microalbuminuria and hs-CRP were significantly correlated with each other (γ = 0.413, P = .003). Conclusions: The dual ARB/PPARγ agonist telmisartan achieved more microalbuminuria reduction than an ARB with no PPARγ agonistic action, possibly through suppression of the inflammatory state in metabolic hypertensive patients.

Original languageEnglish
Pages (from-to)565-572
Number of pages8
JournalAmerican Journal of Hypertension
Volume20
Issue number5
DOIs
StatePublished - May 2007
Externally publishedYes

Keywords

  • HMW adiponectin
  • PPARγ
  • Telmisartan
  • inflammation
  • microalbuminuria

Fingerprint

Dive into the research topics of 'The Differential Effects of Angiotensin II Type 1 Receptor Blockers on Microalbuminuria in Relation to Low-Grade Inflammation in Metabolic Hypertensive Patients'. Together they form a unique fingerprint.

Cite this